Literature DB >> 15829261

Diclofenac, a nonsteroidal anti-inflammatory drug, activates the transient outward K+ current in rat cerebellar granule cells.

Lin-Yun Liu1, Xiao-Wei Fei, Zhao-Ming Li, Zhi-Hong Zhang, Yan-Ai Mei.   

Abstract

Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), has been widely investigated in terms of its pharmacological action, but less is known about its direct effect on ion channels. Here, the effect of diclofenac on voltage-dependent transient outward K+ currents (I(A)) in cultured rat cerebellar granule cells was investigated using the whole-cell voltage-clamp technique. At concentrations of 10(-5)-10(-3) M, diclofenac reversibly increased the I(A) amplitude in a dose-dependent manner and significantly modulated the steady-state inactivation properties of the I(A) channels, but did not alter the steady-state activation properties. Furthermore, diclofenac treatment resulted in a slightly accelerated recovery from I(A) channel inactivation. Intracellular application of diclofenac could mimic the effects induced by extracellular application, although once the intracellular response reached a plateau, extracellular application of diclofenac could induce further increases in the current. These observations indicate that diclofenac might exert its effects on the channel protein at both the inner and outer sides of the cell membrane. Our data provide the first evidence that diclofenac is able to activate transient outward potassium channels in neurons. Although further work will be necessary to define the exact mechanism of diclofenac-induced I(A) channel activation, this study provides evidence that the nonsteroidal anti-inflammatory drug, diclofenac, may play a novel neuronal role that is worthy of future study.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15829261     DOI: 10.1016/j.neuropharm.2004.12.020

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  7 in total

1.  Induction of a novel cation current in cardiac ventricular myocytes by flufenamic acid and related drugs.

Authors:  R Macianskiene; A Gwanyanya; K R Sipido; J Vereecke; K Mubagwa
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

2.  Diclofenac, a Non-steroidal Anti-inflammatory Drug, Inhibits L-type Ca Channels in Neonatal Rat Ventricular Cardiomyocytes.

Authors:  Oleg V Yarishkin; Eun Mi Hwang; Donggyu Kim; Jae Cheal Yoo; Sang Soo Kang; Deok Ryoung Kim; Jae-Hee-Jung Shin; Hye-Joo Chung; Ho-Sang Jeong; Dawon Kang; Jaehee Han; Jae-Yong Park; Seong-Geun Hong
Journal:  Korean J Physiol Pharmacol       Date:  2009-12-31       Impact factor: 2.016

3.  Neuregulin-1/ErbB4 signaling regulates Kv4.2-mediated transient outward K+ current through the Akt/mTOR pathway.

Authors:  Jin-Jing Yao; Ji Sun; Qian-Ru Zhao; Chang-Ying Wang; Yan-Ai Mei
Journal:  Am J Physiol Cell Physiol       Date:  2013-05-22       Impact factor: 4.249

4.  Selenomethionine reduces visual deficits due to developmental methylmercury exposures.

Authors:  Daniel N Weber; Victoria P Connaughton; John A Dellinger; David Klemer; Ava Udvadia; Michael J Carvan
Journal:  Physiol Behav       Date:  2007-09-05

5.  Prenatal exposure of diclofenac sodium alters the behavioral development of young Wistar rats.

Authors:  Birsen Elibol; Begüm Aritan Oğur; Havva Doğru
Journal:  Turk J Biol       Date:  2019-10-14

6.  Neuritin activates insulin receptor pathway to up-regulate Kv4.2-mediated transient outward K+ current in rat cerebellar granule neurons.

Authors:  Jin-Jing Yao; Xiao-Fei Gao; Chi-Wing Chow; Xiao-Qin Zhan; Chang-Long Hu; Yan-Ai Mei
Journal:  J Biol Chem       Date:  2012-10-12       Impact factor: 5.157

7.  Diclofenac prolongs repolarization in ventricular muscle with impaired repolarization reserve.

Authors:  Attila Kristóf; Zoltán Husti; István Koncz; Zsófia Kohajda; Tamás Szél; Viktor Juhász; Péter Biliczki; Norbert Jost; István Baczkó; Julius Gy Papp; András Varró; László Virág
Journal:  PLoS One       Date:  2012-12-31       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.